Investigation of the cell bound vs free concentration of natalizumab in CSF and blood in patients with multiple sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2015
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics; Pharmacokinetics
- 19 Dec 2015 New trial record